Osaka, Japan

Yuki Bessho

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuki Bessho. Retrieved from https://idiyas.com/inventor/yuki-bessho-na0k43p8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuki Bessho: Innovator in HIV Research

Introduction

Yuki Bessho is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of anti-HIV agents. His innovative work has led to the creation of a unique compound that holds promise in the fight against HIV.

Latest Patents

Yuki Bessho holds a patent for "Substituted thiazoles as HIV integrase inhibitors." This invention addresses a critical problem by providing a novel 1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine derivative, or a pharmaceutically acceptable salt or solvate thereof, which is useful as an anti-HIV agent. The compound is represented by a specific formula, as detailed in the patent specification.

Career Highlights

Bessho is currently associated with Japan Tobacco Inc., where he continues to engage in groundbreaking research. His work has not only advanced scientific understanding but also contributed to potential therapeutic solutions for HIV.

Collaborations

Yuki Bessho has collaborated with esteemed colleagues, including Susumu Miyazaki and Kaoru Adachi, who have supported his research endeavors. Their combined expertise has enhanced the development of innovative solutions in the pharmaceutical field.

Conclusion

Yuki Bessho's contributions to HIV research exemplify the impact of innovation in medicine. His patent and ongoing work at Japan Tobacco Inc. highlight the importance of scientific collaboration and dedication to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…